Is xenotransplantation a viable solution to the organ shortage?

How close are we to actually using pig organs in humans?

The most advanced experiment to date is a 2023 study where scientists engineered a pig with 69 genetic edits—removing sugars that trigger rejection, adding human 'protective' proteins, and inactivating viruses—and transplanted its kidneys into monkeys. Those kidneys survived significantly longer than kidneys from pigs with only three edits [7]. This shows that genetic engineering is key to overcoming the immune barrier, but even the best results in monkeys have not yet matched the years-long survival of human donor kidneys.

In humans, the first clinical trial made headlines in January 2022 when a genetically modified pig heart was transplanted into a 57-year-old man at the University of Maryland. He lived for two months before the organ failed [2]. That single case proves the concept is possible, but it also highlights how much work remains: the patient died from a combination of immune rejection and infection, and the full reasons for failure are still being studied [3].

What are the biggest obstacles: cost, safety, and ethics?

Cost is a major unknown. A 2025 analysis estimates that the surgery and immunosuppression for a pig organ will cost about the same as a human organ transplant, but the price of purchasing a gene-edited pig organ could be 'considerable' [1]. The same paper notes that while xenotransplantation could save money by eliminating years of dialysis or mechanical heart support, the sheer number of new transplants would drive up total healthcare spending [1]. So it may not be a cheap fix.

Safety risks are equally serious. The biggest concern is that pig organs might carry viruses—called porcine endogenous retroviruses—that could infect humans and potentially spark a new epidemic [9][13]. Even with gene editing to inactivate these viruses, the risk is not zero [7]. Another paper warns that lifelong monitoring of recipients and their close contacts would be required, which raises privacy and consent issues [9].

Ethically, the picture is mixed. On one hand, xenotransplantation could help patients who are currently denied human organs—for example, children with genetic disabilities like trisomy 21, who are often deemed ineligible due to organ scarcity [8]. On the other hand, critics argue that the high cost and corporate control of the technology could worsen health inequalities, making it available only to the wealthy [5]. Religious perspectives are generally supportive: Jewish and Muslim traditions permit pig organ transplants to save a life, despite dietary restrictions [12][13].

Is xenotransplantation better than other ways to solve the organ shortage?

Several papers argue that other strategies—like improving organ donation rates, using organs from deceased donors more efficiently, and preventing chronic diseases that lead to organ failure—are safer, cheaper, and more ethical than xenotransplantation [6]. For example, policy changes in the U.S. could increase organ recovery and utilization without any new technology [4]. A 2026 review concludes that these alternatives should be prioritized by policymakers over xenotransplantation [6].

However, even the strongest advocates of alternative approaches acknowledge that xenotransplantation is the only option that could provide an unlimited supply of organs on demand [10]. The key trade-off is this: xenotransplantation offers a potential cure for the shortage, but it comes with risks and costs that other strategies do not. For now, it remains a high-stakes research avenue rather than a practical solution.

About These Sources

This answer is built on 13 peer-reviewed studies — published from 2022 to 2026, 6 from 2024 or later, 5 in Q1 journals, collectively cited 355 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 43 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions